CD274 and melanoma: In a meta-analysis of 3107 patients with various solid tumor types including lung, gastrointestinal tract, liver, and genitourinary system carcinomas, melanoma, glioblastoma, mesothelioma, and oral squamous cell carcinoma [19], it was reported that the median percentage of solid tumors with PD-L1 expression was 52.5%.